From June 5th to 8th, the high-profile well-anticipated 2023 BIO International Convention was convened by the Boston Convention & Exhibition Center in the United States. This grand distinguished event had attracted biopharmaceutical companies, investors, and partners worldwide. A variety of cooperative activities were held during the exhibition, providing a platform of presentation and promotion for global enterprises, technology parks, and R&D institutions. With the Cangzhou GMP manufacturing base project, Laviana Pharma made its appearance at this conference, presenting the Company's latest innovative R&D achievements in the Contract Development and Manufacturing Organization (CDMO) industry.

The BIO International Convention, established in 1993, is the world's largest grand event in the biotechnology industry. It gathers the industry-leading biopharmaceutical companies, investors, and partners from around the world, and has colorful collaborative activities held during the conference, providing a platform of presentation and promotion for companies, technology parks, and R&D institutions from various countries. The conference is sponsored by the Biotechnology Innovation Organization (BIO). The BIO is the world's largest biotechnology industry association representing biotechnology companies, academic institutions, and related institutions, whose members cover the United States and 30 other countries.

Upon this occasion, Laviana Pharma presents itself along with the Cangzhou GMP manufacturing base project at 2023 BIO International Convention, which is a comprehensive all-around manifestation of the technical strength and innovative achievements in the field of CDMO. As the global pharmaceutical technology industry growingly develops and upgrades, CDMO has become an integral part of the pharmaceutical industry, and Laviana Pharma will keep dedicating to providing important technical support and guarantee for innovative drugs.

Laviana Pharma’s Cangzhou GMP manufacturing base project is located at Cangzhou National Lingang Technology Development Zone, Huanghua City, Hebei Province, covering a total floor area of 66,000 square meters. With the complete manufacturing facilities and technologies and the equipped main process equipment such as reaction kettles made of materials including 200 L - 6300 L glass lining, stainless steel, Hastelloy etc, horizontal centrifuges, and one-in-three devices, it has the capacity to provide one-stop CDMO services for domestic and global biopharmaceutical enterprises.